NPM1

Unique Identifier:

ML-H026


Name on Requisition:

NPM1


Product Line:

HEME


Panel Group:

NGS


Methodology

Molecular
NGS


Test Description and clinical significance

Genes
NPM1

Disease:
AML

Nucleophosmin (NPM1) is a multifunctional protein involved in ribosome biogenesis, centrosome duplication, and genomic stability. Mutations in NPM1, most commonly frame-shift insertions in exon 12, are among the most frequent genetic alterations in acute myeloid leukemia (AML). NPM1 mutations define a distinct AML subtype, often associated with normal karyotype, and provide important diagnostic and prognostic information, as well as guidance for risk stratification and therapy decisions. This assay specifically detects clinically relevant mutations in exon 12 of NPM1.


Specimen Requirements

Preparation:
PB, BM

Collection:
At least 0.5 ml EDTA, citrate (ACD) or Heparinized whole blood or bone marrow aspirates for DNA mutations

Stability:
96hours/4 to 7 days refrigerated

Unacceptable Conditions:
Specimen submitted is in the incorrect fixative or anticoagulant. Specimen received after the stability date. Gross hemolysis. Frozen specimen. Insufficient specimen. Unlabeled. Left un-refrigerated for an extended period.


Storage & Transport

Blood or bone marrow specimens should be kept at room temperature and preferably received within 96 hrs of drawing. Samples that are 4 to 7 days old should be refrigerated. Sufficient quantity of previously extracted DNA is acceptable if stored at appropriate temperature (short term at 2–8oC or long term at -15 to -25 oC) and should be transported on ice.


CPT(s)

81310


New York Approved

Yes


TAT

5


Requisition Type

Heme


Levels of Service

Full


DexS Code

NONE


Prefix

MI


*The CPT codes provided are for informational purposes only and are based on AMA guidelines The billing party is solely responsible for correct CPT coding.

Discover more.

A Model Experience

With core values rooted in service and integrity, our leadership team sets the bar high.

We consistently strive to set the model for exactly how a reference laboratory should engage with both physicians and patients.

Accredited and Certified

siParadigm is accredited by CLIA (Clinical Laboratory Improvement Amendments) and certified by CAP (College of American Pathologists).

We also hold select state licensure where required.